An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant
2018/3/27
Journal of Clinical Oncology (JCO) Podcast
Frequently requested episodes will be transcribed first
Shownotes Transcript
No transcript made for this episode yet, you may request it for free.